Department of Radiation Oncology, Samsung Medical Center, Seoul, Korea.
Sungkyunkwan University School of Medicine, Seoul, Korea.
Clin Mol Hepatol. 2021 Jan;27(1):144-156. doi: 10.3350/cmh.2020.0095. Epub 2020 Dec 7.
BACKGROUND/AIMS: The abscopal effect, a rare phenomenon induced by radiation, can be reinforced by immunotherapy. Although radiation therapy and immunotherapy are increasingly being utilized for the treatment of hepatocellular carcinoma (HCC), whether immunotherapy could boost the abscopal effect remains unclear. In this study, we aimed to elucidate the immunological mechanisms underlying the abscopal effect induced by the combination of irradiation and immunotherapy in a murine HCC model.
A syngeneic HCC mouse model was established by transplanting murine Hepa 1-6 HCC cells into both hind legs of immunocompetent C57BL/6 mice. The tumors on the right hind legs were irradiated, and abscopal effects were observed in the non-irradiated tumors on the left hind leg with or without the coadministration of anti-programmed cell death 1 (PD-1) antibodies. Flow cytometric analyses were performed to analyze the distributions of immune cells infiltrating both irradiated and non-irradiated tumors and the tumor-draining lymph nodes (TDLNs).
Administration of 16 Gy in two fractions more effectively inhibited the growth of both irradiated and nonirradiated tumors with higher tumor infiltration of cytotoxic T cells than 8 Gy did in a single fraction. The higher dose also increased activated dendritic cells in TDLNs, which had higher expression of the programmed cell death ligand 1. Coadministration of anti-PD-1 antibodies significantly enhanced the abscopal effect and increased infiltration of activated cytotoxic T cells in both irradiated and non-irradiated tumors.
Our findings show that adding anti-PD-1 therapy to radiation enhanced the abscopal effect in a syngeneic murine model of HCC.
背景/目的:远隔效应是一种由辐射诱导的罕见现象,可以通过免疫疗法来增强。虽然放射治疗和免疫疗法越来越多地被用于治疗肝细胞癌(HCC),但免疫疗法是否能增强远隔效应尚不清楚。在这项研究中,我们旨在阐明照射和免疫疗法联合治疗在小鼠 HCC 模型中诱导远隔效应的免疫机制。
通过将小鼠 Hepa 1-6 HCC 细胞移植到免疫功能正常的 C57BL/6 小鼠的两条后腿中,建立了同源 HCC 小鼠模型。对右后腿的肿瘤进行照射,并观察到左后腿未照射肿瘤的远隔效应,同时或不联合使用抗程序性细胞死亡蛋白 1(PD-1)抗体。进行流式细胞术分析以分析浸润照射和未照射肿瘤以及肿瘤引流淋巴结(TDLNs)的免疫细胞分布。
分两次给予 16 Gy 比单次给予 8 Gy 更有效地抑制了照射和未照射肿瘤的生长,并且肿瘤浸润的细胞毒性 T 细胞更多。更高的剂量还增加了 TDLNs 中的活化树突状细胞,其程序性细胞死亡配体 1 的表达更高。联合使用抗 PD-1 抗体显著增强了远隔效应,并增加了照射和未照射肿瘤中活化细胞毒性 T 细胞的浸润。
我们的研究结果表明,在同源性小鼠 HCC 模型中,将抗 PD-1 治疗与放射治疗联合使用可增强远隔效应。